Skip to main content

Table 1 Patient Information

From: Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection

Patient Date HIV+ Date Death1 Prior Therapy2 Visit 1 Visit 2 Visit 3
     Date VL3 CD4 Count4 Therapy Date VL3 CD4 Count4 Therapy Date VL3 CD4 Count4 Therapy
#1 Jun. 1 1986 -- AZT Apr. 7 1993 2.7 264 ddI, AZT Jan. 19 1994 2.4 210 ddI, AZT Oct. 26 1994 3.5 190 AZT
#2 Jan. 1 1989 Oct. 16 1994 ddI Apr. 7 1993 6.4 187 ddI Jan. 26 1994 5.6 40 D4T Sept. 14 1994 5.8 18 None
#3* Nov. 1 1989 -- ddI Apr. 6 1993 4.3 144 ddI Jan. 26 1994 5.3 162 AZT Sept. 13 1994 5.6 77 AZT
#7* Jun. 1 1987 -- AZT Apr. 21 1993 4.5 270 ddI Jan. 26 1994 4.9 234 ddI Mar. 9 1995 4.5 146 AZT
#8* Oct. 1 1988 -- AZT Apr. 21 1993 3.3 475 ddI Jan. 12 1994 3.5 338 ddI Nov. 16 1994 4.4 325 ddI
#19* Jan. 1 1991 -- ddI Jun. 2 1993 3.9 77 ddI Jan. 26 1994 5.3 22 AZT Nov. 14 1994 4.7 42 AZT
#60 Dec. 1 1988 Apr. 3 1998 AZT Sept. 14 1994 4.5 48 AZT Jun. 14 1995 4.9 51 AZT Feb. 28 1996 5.3 21 ddI
#42 Nov. 1 1989 Oct. 21 1993 AZT, ddC Oct. 6 1993 5.6 9 None         
  1. 1Patient #42 passed away during the study and only visit 1 samples were available
  2. 2Antiretroviral therapy in the 6 months preceding visit 11
  3. 3VL - log plasma viral load in log10 (copies)/mL
  4. 4CD4+ cell counts in cells/μL
  5. *Patients for which a 2007 PBL sample was analyzed